Ibrutinib and venetoclax for first-line treatment of CLL
Research output: Contribution to journal › Comment/debate › Research › peer-review
| Original language | English |
|---|---|
| Journal | New England Journal of Medicine |
| Volume | 381 |
| Issue number | 8 |
| Pages (from-to) | 788-789 |
| Number of pages | 2 |
| ISSN | 0028-4793 |
| DOIs |
|
| Publication status | Published - 2019 |
ID: 240637754